BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMA (HGG): ANALYSIS OF MONOTHERAPY VERSUS COMBINATION WITH CHEMOTHERAPY FROM A CANADIAN RETROSPECTIVE CHART REVIEW

被引：0
|
作者：
Kavan, Petr [1 ]
Sahebjam, Solmaz [2 ]
Garoufalis, Evgenia [3 ]
Guiot, Marie-Christine [4 ]
Muanza, Thierry
Del Maestro, Rolando [5 ]
Petrecca, Kevin [5 ]
Sharma, Rajesh [3 ]
机构：
[1] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Montreal, PQ H3A 1A1, Canada
[2] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[3] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
[4] Montreal Neurol Hosp, Inst Neuropathol, Montreal, PQ, Canada
[5] McGill Univ, Ctr Hlth, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada
来源：
NEURO-ONCOLOGY | 2012年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：76 / 76
页数：1
相关论文
共 50 条
  • [11] Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients
    Beatrice Detti
    Silvia Scoccianti
    Maria Ausilia Teriaca
    Virginia Maragna
    Victoria Lorenzetti
    Sara Lucidi
    Chiara Bellini
    Daniela Greto
    Isacco Desideri
    Lorenzo Livi
    La radiologia medica, 2021, 126 : 1249 - 1254
  • [12] Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients
    Detti, Beatrice
    Scoccianti, Silvia
    Teriaca, Maria Ausilia
    Maragna, Virginia
    Lorenzetti, Victoria
    Lucidi, Sara
    Bellini, Chiara
    Greto, Daniela
    Desideri, Isacco
    Livi, Lorenzo
    RADIOLOGIA MEDICA, 2021, 126 (09): : 1249 - 1254
  • [13] BEVACIZUMAB AND CARBOPLATIN FOR RECURRENT HIGH-GRADE GLIOMA
    Mrugala, Maciej M.
    Lee, Laurie K.
    Graham, Carrie A.
    Fink, James R.
    Spence, Alexander M.
    NEURO-ONCOLOGY, 2010, 12 : 55 - 55
  • [14] Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma
    Drappatz, J.
    Lee, E. Q.
    Hammond, S.
    Grimm, S. A.
    Norden, A. D.
    Beroukhim, R.
    Gerard, M.
    Schiff, D.
    Chi, A. S.
    Batchelor, T. T.
    Doherty, L. M.
    Ciampa, A. S.
    LaFrankie, D. C.
    Ruland, S.
    Snodgrass, S. M.
    Raizer, J. J.
    Wen, P. Y.
    JOURNAL OF NEURO-ONCOLOGY, 2012, 107 (01) : 133 - 138
  • [15] Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma
    J. Drappatz
    E. Q. Lee
    S. Hammond
    S. A. Grimm
    A. D. Norden
    R. Beroukhim
    M. Gerard
    D. Schiff
    A. S. Chi
    T. T. Batchelor
    L. M. Doherty
    A. S. Ciampa
    D. C. LaFrankie
    S. Ruland
    S. M. Snodgrass
    J. J. Raizer
    P. Y. Wen
    Journal of Neuro-Oncology, 2012, 107 : 133 - 138
  • [16] Anlotinib Alone or in Combination With Temozolomide in the Treatment of Recurrent High-Grade Glioma: A Retrospective Analysis
    Yang, Qunying
    Guo, Chengcheng
    Lin, Xiaoping
    Luo, Lili
    He, Zhenqiang
    Lin, Fuhua
    Zhang, Ji
    Chen, Yinsheng
    Jiang, Xiaobing
    Ke, Chao
    Mou, Yonggao
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [17] RE-IRRADIATION WITH AND WITHOUT BEVACIZUMAB IN RECURRENT OR PROGRESSIVE HIGH-GRADE GLIOMAS (HGG): RETROSPECTIVE ANALYSIS OF 13 PATIENTS
    Hundsberger, T.
    Bruegge, D.
    Weder, P.
    Weber, J.
    Plasswilm, L.
    NEURO-ONCOLOGY, 2012, 14 : 88 - 88
  • [18] Bevacizumab in Recurrent High-Grade Glio as: A Canadian Perspective
    Fat, Mary Jane Lim
    Maganti, Manjula
    Maurice, Catherine
    Mason, Warren
    NEUROLOGY, 2016, 86
  • [19] Re-Irradiation with Bevacizumab in recurrent high-grade Glioma
    Niyazi, M.
    Ganswindt, U.
    Schwarz, S. B.
    Schnell, O.
    Belka, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 75 - 75
  • [20] Surgery for Recurrent High-Grade Glioma After Treatment with Bevacizumab
    Blumenthal, Deborah T.
    Kanner, Andrew A.
    Aizenstein, Orna
    Cagnano, Emanuela
    Greenberg, Ariel
    Hershkovitz, Dov
    Ram, Zvi
    Bokstein, Felix
    WORLD NEUROSURGERY, 2018, 110 : E727 - E737
12345